Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of pulsatilla saponin B4 in preparation of external medicine for treating psoriasis

A technology of Pulsatilla saponins and external medicines, which is applied in the field of medicine and can solve the problems of obvious side effects and large doses

Pending Publication Date: 2022-07-08
SUZHOU UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In particular, the present invention avoids the problems of obvious side effects and large doses of oral administration, and the therapeutic effect of external administration is significantly better than that of existing clinical medication, achieving unexpected technical effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pulsatilla saponin B4 in preparation of external medicine for treating psoriasis
  • Application of pulsatilla saponin B4 in preparation of external medicine for treating psoriasis
  • Application of pulsatilla saponin B4 in preparation of external medicine for treating psoriasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1 The effect of Pulsatilla saponin B4 on the PASI score of psoriatic mice

[0035] The experimental results showed that after applying imiquimod, compared with the blank group, the skin of the model group appeared erythema, scaling and infiltration, resulting in psoriasis-like skin lesions. With the continuous effect of the drug, the skin lesions in the model group became more and more serious from the 2nd day, the scales increased and thickened, and the skin infiltration was obvious. The scientific significance indicates that the psoriasis mouse model was successfully established. Compared with the model group, the skin lesions in the high-dose Pulsatilla saponin group were significantly relieved during the same period, the skin was smoother, with almost no erythema and scales, and the infiltration and thickening were very light; the skin of the halometasone-positive drug group was slightly reddish, with less scales and infiltration. Thickening is mild (see f...

Embodiment 2

[0036] Example 2 The effect of Pulsatilla saponin B4 on the erythema score of psoriatic mice

[0037] The erythema on the back of the mice in the model group and the low-dose group began to appear after the 3rd day of medication, and the erythema score increased day by day until the 7th day of the curative effect observation period. , until the 7th day, the erythema began to subside during the observation period, while the skin of the mice in the high-dose group had almost no erythema. Among them, the erythema scores of the model group and the control group were significantly different from 3 to 7 days (P image 3 ). The experimental results suggest that Pulsatilla saponins can significantly reduce the degree of erythema in mice with psoriasis, and the effect is better than that of glucocorticoids.

Embodiment 3

[0038] Example 3 The effect of Pulsatilla saponin B4 on the scale score of mice with psoriasis

[0039] The scales on the back of the mice in the model group and the low-dose group began to appear after the 4th day of treatment, and the scale scores increased day by day until the 7th day of efficacy observation period, while the back of the mice in the high-dose group only began to appear fine scales after the 7th day of treatment. , the positive drug group did not appear scales for 7 days. Among them, there were statistically significant differences in the scale scores between the model group and the control group on days 4-5 (P Figure 4 ). The experimental results suggest that Pulsatilla saponins can significantly reduce the scale of psoriatic mice, and the effect is comparable to that of glucocorticoids.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a medicine technology, and particularly relates to application of pulsatilla saponin B4 in preparation of a medicine for treating psoriasis. In recent years, researches on some traditional Chinese medicines and active components separated from the traditional Chinese medicines find that traditional Chinese medicine prescriptions and single traditional Chinese medicines which have the main effects of clearing heat, cooling blood, promoting blood circulation, removing blood stasis, nourishing blood and moistening dryness, and also have the effects of tonifying spleen, promoting diuresis, detoxifying and removing stasis have different degrees of anti-psoriasis effects, but the effects of the existing traditional Chinese medicines need to be improved. According to the invention, the pulsatilla saponin B4 is used as an active component to prepare an external application medicament for the first time, the use is convenient, and side effects are avoided while the treatment effect better than that of the existing western medicine is exerted.

Description

technical field [0001] The invention belongs to pharmaceutical technology, and particularly relates to the application of Pulsatilla saponin B4 in the preparation of external medicine for treating psoriasis. Background technique [0002] Psoriasis, also known as "psoriasis", is an inflammatory persistent skin disease. It is a common intractable chronic inflammatory skin disease in dermatology. Complications such as psoriatic arthritis, cardiovascular and cerebrovascular complications of psoriasis, and metabolic syndrome often bring physical pain and greater economic burden to patients. At present, its pathogenesis is believed to be caused by the interaction between the immune system, self-antigens and various environmental factors, and is related to inducing factors such as infection, trauma, environment and drugs. Psoriasis is pathologically characterized by epidermal hyperplasia caused by hyperproliferation of keratinocytes and manifests in various phenotypes, including p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/704A61K36/71A61P17/06A61P17/00A61P3/00A61K125/00
CPCA61K31/704A61K36/71A61K9/0014A61P17/06A61P17/00A61P3/00
Inventor 刘艳丽许琼明苏疏影
Owner SUZHOU UNIV